RxDoctor Payments Data

Ryan Gerritsen, MD

Otolaryngology/Facial Plastic Surgery · Akron, OHNPI 1548689730

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,316 of the $4,522 with a category attached, or 73.3%. 15 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 53.3% of the total. Reporting peaked in 2023 at $2,130 and has fallen 52.3% since, to $1,016 in 2025.

$4,522in general payments, 2019–2025

Across 87 payments — averaging $51.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$2K
  • Sanofi$487
  • Regeneron Healthcare Solutions, Inc.$339
  • Optinose US, Inc.$297
  • Stryker$228
  • GSK$192
  • plus $567 from 9 others

What the payments were for

  • Travel & lodging$91620%
  • Food & beverage$3,31673%
  • Education$2916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,522 in reported general payments places this provider in the 75th percentile of 29 otolaryngology/facial plastic surgery providers in Ohio.

See all otolaryngology/facial plastic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$69,054
Medicare patients
193
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth31$4,093
Ipratropium Bromide75$4,057
Cevimeline Hcl13$4,023
Fluocinolone Acetonide Oil34$1,660
Omeprazole159$1,610
Azelastine Hcl66$1,594
Pilocarpine Hcl15$1,287
Cefdinir61$940
Fluticasone Propionate43$632
Mupirocin71$538
Ofloxacin20$527
Famotidine41$332
Methylprednisolone52$315
Doxycycline Hyclate32$247
Pantoprazole Sodium16$207

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →